BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 31545517)

  • 1. Nitric Oxide-Mediated Resistance to Antitumor Photodynamic Therapy.
    Girotti AW
    Photochem Photobiol; 2020 May; 96(3):500-505. PubMed ID: 31545517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple Means by Which Nitric Oxide can Antagonize Photodynamic Therapy.
    Girotti AW; Fahey JM; Korytowski W
    Curr Med Chem; 2016; 23(24):2754-2769. PubMed ID: 27776475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pro-Tumor Activity of Endogenous Nitric Oxide in Anti-Tumor Photodynamic Therapy: Recently Recognized Bystander Effects.
    Girotti AW; Bazak J; Korytowski W
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of nitric oxide in tumor cells as a negative adaptation to photodynamic therapy.
    Girotti AW
    Lasers Surg Med; 2018 Jul; 50(5):590-598. PubMed ID: 29504635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide-mediated resistance to photodynamic therapy in a human breast tumor xenograft model: Improved outcome with NOS2 inhibitors.
    Fahey JM; Girotti AW
    Nitric Oxide; 2017 Jan; 62():52-61. PubMed ID: 28007662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accelerated migration and invasion of prostate cancer cells after a photodynamic therapy-like challenge: Role of nitric oxide.
    Fahey JM; Girotti AW
    Nitric Oxide; 2015 Sep; 49():47-55. PubMed ID: 26068242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced aggressiveness of bystander cells in an anti-tumor photodynamic therapy model: Role of nitric oxide produced by targeted cells.
    Bazak J; Fahey JM; Wawak K; Korytowski W; Girotti AW
    Free Radic Biol Med; 2017 Jan; 102():111-121. PubMed ID: 27884704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitric oxide antagonism to glioblastoma photodynamic therapy and mitigation thereof by BET bromodomain inhibitor JQ1.
    Fahey JM; Stancill JS; Smith BC; Girotti AW
    J Biol Chem; 2018 Apr; 293(14):5345-5359. PubMed ID: 29440272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Endogenous Nitric Oxide in Hyperaggressiveness of Tumor Cells that Survive a Photodynamic Therapy Challenge.
    Girotti AW
    Crit Rev Oncog; 2016; 21(5-6):353-363. PubMed ID: 29431083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of pro-tumor nitric oxide by anti-tumor photodynamic therapy.
    Girotti AW; Fahey JM
    Biochem Pharmacol; 2020 Jun; 176():113750. PubMed ID: 31836386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonistic Effects of Endogenous Nitric Oxide in a Glioblastoma Photodynamic Therapy Model.
    Fahey JM; Emmer JV; Korytowski W; Hogg N; Girotti AW
    Photochem Photobiol; 2016 Nov; 92(6):842-853. PubMed ID: 27608331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Negative Impact of Cancer Cell Nitric Oxide on Photodynamic Therapy.
    Fahey JM; Girotti AW
    Methods Mol Biol; 2022; 2451():21-31. PubMed ID: 35505007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide-elicited resistance to anti-glioblastoma photodynamic therapy.
    Girotti AW; Fahey JM; Korytowski W
    Cancer Drug Resist; 2020 3rd Quarter; 3(3):401-414. PubMed ID: 33073206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bystander Effects of Nitric Oxide in Cellular Models of Anti-Tumor Photodynamic Therapy.
    Bazak J; Korytowski W; Girotti AW
    Cancers (Basel); 2019 Oct; 11(11):. PubMed ID: 31661869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upstream signaling events leading to elevated production of pro-survival nitric oxide in photodynamically-challenged glioblastoma cells.
    Fahey JM; Korytowski W; Girotti AW
    Free Radic Biol Med; 2019 Jun; 137():37-45. PubMed ID: 30991141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid upregulation of cytoprotective nitric oxide in breast tumor cells subjected to a photodynamic therapy-like oxidative challenge.
    Bhowmick R; Girotti AW
    Photochem Photobiol; 2011; 87(2):378-86. PubMed ID: 21143607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-generated nitric oxide as an antagonist of photodynamic therapy.
    Girotti AW
    Photochem Photobiol Sci; 2015 Aug; 14(8):1425-32. PubMed ID: 25706541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric Oxide Inhibition of Chain Lipid Peroxidation Initiated by Photodynamic Action in Membrane Environments.
    Girotti AW; Korytowski W
    Cell Biochem Biophys; 2020 Jun; 78(2):149-156. PubMed ID: 32303898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric Oxide-elicited Resistance to Antitumor Photodynamic Therapy via Inhibition of Membrane Free Radical-mediated Lipid Peroxidation.
    Girotti AW
    Photochem Photobiol; 2021 Jul; 97(4):653-663. PubMed ID: 33369741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric Oxide Antagonism to Anti-Glioblastoma Photodynamic Therapy: Mitigation by Inhibitors of Nitric Oxide Generation.
    Fahey JM; Girotti AW
    Cancers (Basel); 2019 Feb; 11(2):. PubMed ID: 30781428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.